Sorry, you need to enable JavaScript to visit this website.
  • Globant and Medocity Announce a Strategic Partnership to Accelerate Digitalization of Clinical Research

  • 07 Aug 2023

    Press Release

Globant & Medocity

Globant combines the breadth of its technology capabilities with the life sciences industry expertise.

This partnership will help to accelerate the digitalization of clinical research.


San Francisco – August 7, 2023 - Globant, a digitally native company focused on reinventing businesses through innovative technology solutions, today announced a partnership with Medocity, a leading digital health solutions and SaaS platform provider. This association will leverage Globant’s digital strategy, digital IQ, data and system integration, and software engineering expertise to implement comprehensive digital solutions in support of clinical research operations from study design, through patient identification and recruitment, study conduct and patient engagement, to data collection, data analysis, and reporting. 


“We’re joining forces with Medocity to bring an end-to-end offering for digitalization of clinical research to our customers,” said Basia Coulter, Global Director for Healthcare and Life Sciences at Globant. “By combining Globant’s Digital IQ methodology with Medocity’s REACH platform for recruitment and enrollment and the use of real-world data (RWD), we empower life sciences organizations with a 360 approach to patient recruitment. Additionally, we support our customers by integrating the Medocity DCT platform with other systems to enable efficiencies and streamlined clinical operations processes.”


Medocity is a leading digital health technology company that has been serving the pharmaceutical and life sciences industry for almost a decade. They provide enterprise-level digital health platform solutions, as well as fit-for purpose applications for all phases of research and patient support, that are built to drive efficiencies for pharmaceutical and biotech sponsors and contract research organizations (CROs), as well as to reduce site and patient burden for principal investigators/sites. Medocity has been endorsed year over year by Gartner for the unique attributes of its digital platform and has been rated with high marks for its user experience and ease of use by patients and health care providers.


“We are pleased with our synergistic collaboration with Globant and expanding our smart technology platform solution for recruitment and enrollment around the globe,” said Amy Apostoleris, Global Head of Digital Clinical Trials Solutions. “In concert with Globant’s capabilities we are able to increase patient diversity and provide a total recruitment and enrollment solution through REACHTM which identifies quality patients by leveraging real world data, patient and physician insights and Globant’s outstanding omnichannel digital outreach capabilities.”



About Globant

We are a digitally native company that helps organizations reinvent themselves and unleash their potential. We are the place where innovation, design, and engineering meet at scale.

  • We have more than 27,000 employees and we are present in 25 countries and 5 continents working for companies like Google, Electronic Arts and Santander, among others.
  • We were named a Worldwide Leader in AI Services (2023) and Worldwide Leader in CX Improvement Services (2020) by IDC MarketScape report.
  • We were also featured as a business case study at Harvard, MIT, and Stanford.
  • We are active members of The Green Software Foundation (GSF) and the Cybersecurity Tech Accord.



Sign up to get first dibs on press news and updates.

For more information, visit


About Medocity

Medocity is a leading digital health solutions and SaaS platform provider utilized by pharmaceutical companies, health insurers, and health/hospital systems to transform management of chronic and complex conditions. We enable clients to design next generation digital experiences to support patients throughout their disease journey, drive greater engagement levels, and improve health outcomes. Medocity’s platform is uniquely flexible and highly interoperable – a connected digital ecosystem where patients and clinical teams seamlessly interact in real time, capturing continuous real-world data, generating AI-driven insights, and enabling proactive interventions. 

Medocity Digital Clinical Trials Solutions group provides a comprehensive digital solution for all phases of studies and patient support, with enterprise-level capability that is configurable to be fit for purpose. Its Digital Clinical Trials (DCT) platform for hybrid and decentralized studies provides a fully interactive clinical trial ecosystem that captures valuable real-time clinical insights & real-world data, while engaging patients, sites, and sponsors and enabling early decision making and safety monitoring.  It offers a choice of various modules including informed eConsent, ePRO/eCOA, device connectivity, secured messaging and tele-visit. Medocity’s platform. It seamlessly integrates with EMR, lab, genetic mapping and APCD data, as well as EDC, CTMS and iRT systems to support site and patient identification

Medocity innovative REACHTM  platform and connected ecosystem significantly accelerates recruitment and shortens enrollment timelines.  More importantly, it provides a seamless way to manage and track the recruitment process through its role-based portals for sponsors, treating physicians and trial sites with capabilities to identify, screen, refer, qualify and enroll hard-to-find patients in real-time. 



Globant & Medocity